Different calculation methods for flow cytometric S-phase fraction: Prognostic implications in breast cancer?

Cytometry

Volumn 33, Issue 4, 1998, Pages 385-393

  Baldetorp, Bo ^a   Stål, Olle ^b   Ahrens, Olaf ^c   Cornelisse, Cees ^d   Corver, Willem ^d   Falkmer, Ursula ^e   Fernö, Mårten ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c Ahrens Cytometrie Systeme   (Germany)

^d LEIDEN UNIVERSITY   (Netherlands)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cancer; DNA; Flow cytometry; Prognosis; S phase calculation

Indexed keywords

DNA;

ARTICLE; BREAST CANCER; CANCER SURVIVAL; CELL CYCLE S PHASE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HISTOGRAM; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032402118     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19981201)33:4<385::AID-CYTO1>3.0.CO;2-5     Document Type: Article

References (57)

1. Bagwell CB: PARA2 Program, Easy2 Software, Coulter Electronics, Inc., 1981.
2. Bagwell CB: ModFit program, Verity Software House, Inc. Topsham, ME, 1989.
3. Bagwell CB, Mayo SW, Whetstone SD, Hitchcox SA, Baker DR, Herbert DJ, Weaver DL, Jones MA, Lovett EJ III: DNA histogram debris theory and compensation. Cytometry 12:107-118, 1991.
4. Bagwell CB: Theoretical aspects of flow cytometry data analysis. In: Clinical Flow Cytometry, Principles and Application, 1st ed, Bauer KD, Duque RE, Shankey TV (eds). Williams & Wilkins, Baltimore, 1993, pp. 41-61.
5. Baisch H, Göhde W, Linden WA: Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle. Radiat Environ Biophys 12:31-39, 1975.
6. Baldetorp B, Dahlberg M, Hoist U, Lindgren G: Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm. Cytometry 10:695-705, 1989.
7. Baldetorp B, Bendahl P-O, Fernö M, Alanen K, Delle U, Falkmer U, Hansson-Aggesjö B, Höckenström T, Lindgren A, Mossberg L, Nordling S, Sigurdsson H, Stål O, Visakorpi T: Reproducibility in DNA flow cytometric analysis of breast cancer: Comparison of 12 laboratories' results for 67 sample homogenates. Cytometry 22:115-127, 1995.
8. Barlogie B, Drewinko B, Johnston DA, Buchner T, Hauss WH, Freireich EJ: Pulse cytophotometric analysis of synchronized cells in vitro. Cancer Res 36:1176-1181, 1976.
9. Beck HP: Evaluation of flow cytometric data of human tumors. Correction procedures for background and cell aggregations. Cell Tissue Kinet 13:173-181, 1980.
10. Bergers E, van Diest PJ, Baak JPA: Reproducibility of semi-automated cell cycle analysis of flowcytometric DNA-histograms of fresh breast cancer material. Anal Cell Pathol 8:1-13, 1995.
11. Bergers E, Montironi R, van Diest PJ, Prete E, Baak JPA: Interlaboratory reproducibility of semiautomated cell cycle analysis of flowcytometric DNA-histograms obtained from fresh material of 1295 breast cancer cases. Hum Pathol 27:553-560, 1996.
12. Beauregard P, Witzig TE, Kurtin PJ, Greipp PR, Stenson MJ, Katzmann JA, Habermann TM, Wieand HS: Models of S-phase determination in lymphomas from flow cytometric DNA content histograms: Comparison with the bromodeoxyuridine labeling index. Hematol Pathol 5: 177-183, 1991.
13. Burton KA: Study of the conditions and mechanism of the diphenyl-amine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315-323, 1956.
14. Camplejohn RS, Ash CM, Gillet CE, Raikundalia B, Barnes DM, Gregory WM, Richards MA, Millis RR: The prognostic significance of DNA flow cytometry in breast cancer: esults from 881 patients treated in a single centre. Br J Cancer 71:140-145, 1995.
15. Christensen I, Hartmann NR, Keiding N, Larsen JK, Noer H, Vindeløv L: Statistical analysis of DNA distributions from cell populations with partial synchrony. In: Pulse-Cytophotometry (III), Lutz D (ed). European Press, Ghent, Belgium, 1978, pp. 71-78.
16. Clark GM, Mathieu M-C, Owens MA, Dressier LG, Eudey L, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff MD, McGuire WL: Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. J Clin Oncol 10:428-432, 1992.
17. Cox DR: Regression models and life-tables. J R Stat Soc(B) 34: 187-220, 1972.
18. Dean PN: A simplified method of DNA distribution analysis. Cell Tissue Kinet 13:299-308, 1980.
19. Dean PN, Jett JH: Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol 60:523-527, 1974.
20. Dettmar P, Harbeck N, Thomssen C, Pache L, Ziffer P, Fizi K, Jänicke F, Nathrath W, Schmitt M, Graeff H, Höfler H: Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer. Br J Cancer 75(10):1525-1533, 1997.
21. Feichter G, Czech W, Haag D, Goerttler K, Futterman G, Loehrke H, Abel U: Comparison of S-phase fractions measured by flow cytometry and autoradiography in human transplant tumors. Cytometry 9: 605-611, 1988.
22. Gasparini G, Boracchi P, Verderio P, Bevilacqua P: Cell kinetics in human breast cancer: Comparison between the prognostic value of the cytofluorimetric S-phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunocytochemistry. Int J Cancer 57:822-829, 1994.
23. Haag D, Feichter G, Goerttler K, Kaufmann M: Influence of systematic errors on the evaluation of the S-phase portions from DNA distributions of solid tumors as shown for 328 breast carcinomas. Cytometry 8:377-385, 1987.
24. Hedley DW, Clark GM, Cornelisse CJ, Killander D, Kute T, Merkel D: Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry 14:482-485, 1993.
25. Hiddemann W, Schumann J, Andreeff M, Barlogie B, Herman CJ, Leif RC, Mayall BH, Murphy RF, Sandberg AA: Convention on nomenclature for DNA cytometry. Cytometry 5:445-446, 1984.
26. Joensuu H, Elomaa L, Klemi PJ, Toikkanen S: Comparison of five methods to calculate the S-phase fraction size. Anal Cell Pathol 6:(abstr 252):263, 1994.
27. Kallioniemi O-P, Visakorpi T, Holli K, Heikkinen A, Isola J, Koivula T: Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing. Cytometry 12:413-421, 1991.
28. Kallioniemi O-P, Visakorpi T, Holli K, Isola JJ, Rabinovitch PS: Automated peak detection and cell cycle analysis of flowcytometric DNA histograms. Cytometry 16:250-255, 1994.
29. Kute TE, Quadri Y, Muss H, Zbieranski N, Cirrincione C, Berry DA, Barcos M, Thor AP, Liu E, Koerner F, Henderson IC: Flow cytometry in node-positive breast cancer: Cancer and leukemia group B protocol 8869. Cytometry 22:297-306, 1995.
30. Lampariello F, Del Bino G: Automatic parameter estimation of flow cytometric DNA distributions in the study of cell kinetics. Int Fed Autom Cont, Pergamon Press, New York, 1988.
31. Lee GM, Thornthwaite JT, Rasch EM: Picogram per cell determination of DNA by flow cytofluorometry. Anal Biochem 137:221-226, 1984.
32. Lowry OH, Rosebrough NJ, Farr L, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951.
33. Marquardt DW: An algorithm for least-squares estimation of nonlinear parameters. Soc Ind Appl Math 11:431-441, 1963.
34. McDivitt RW, Stone KR, Craig RB, Meyer JS: A comparison of human breast cancer cell kinetics measured by flow cytometry and thymidine labeling. Lab Invest 52:287-291, 1985.
35. Merkel DE, Winchester DJ, Goldschmidt RA, August CZ, Wruck DM, Rademaker AW: DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancer. Cancer 72:1926-1932, 1993.
36. Meyer JS, Coplin MD: Thymidine labeling index, flowcytometric S-phase measurement, and DNA index in human tumors. Comparisons and correlations. Am J Clin Pathol 89:586-595, 1988.
37. Meyer JS, Province MA: S-phase fraction and nuclear size in long term prognosis of patients with breast cancer. Cancer 74:2287-2299, 1994.
38. Rabinovitch PS, Shen W-T: Multiplus program. Phoenix Flow Systems, San Diego, CA, 1988.
39. Rabinovitch PS: Numerical compensation for the effects of cell clumping on DNA content histograms. Cytometry Suppl 4:27, 1991.
40. Rabinovitch PS: Practical considerations for DNA content and cell cycle analysis. In: Clinical Flow Cytometry, Principles and Application, 1st ed, Bauer KD, Duque RE, Shankey TV (eds). Williams & Wilkins, Baltimore, 1993, pp. 117-142.
41. Romero H, Schneider J, Burgos J, Bilbao J, Rodriguez-Escudero FJ: S-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers. Breast Cancer Res Treat 38:265-275, 1996.
42. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, Mayall BH, Wheeless L: Guidelines for implementation of clinical cytometry. Cytometry 14:472-477, 1993.
43. Sigurdsson H, Baldetorp B, Borg Å, Dalberg M, Fernö M, Killander D, Olsson H: Indicators of prognosis in node-negative breast cancer. N Engl J Med 322:1045-1053, 1990.
44. Silvestrini R, Daidone MG, Del Bino G, Mastore M, Luisi A, Di Fronzo G, Boracchi P: Prognostic significance of proliferative activity and ploidy in node-negative breast cancers. Annals Oncol 4:213-219, 1993.
45. Stanton PD, Cooke TG, Oakes SJ, Winstanley J, Holt S, George WD, Murray GD: Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer. Br J Cancer 66:925-929, 1992.
46. Stål O, Carstensen J, Hatschek T, Nordenskjöld B: Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients. Br J Cancer 66: 706-711, 1992.
47. Stål O, Dufmats M, Hatschek T, Carstensen J, Klintenberg C, Rutqvist L-E, Skoog L, Sullivan S, Wingren S, Nordenskjöld B: S-phase fraction is a prognostic factor in stage I breast carcinoma. J Clin Oncol 11: 1717-1722, 1993.
48. Stål O, Baldetorp B: S-phase fraction assessed by a variant of the rectangular model adapted to the flow cytometric DNA histogram profile. Cytometry 33:487-491, 1998.
49. Thornthwaite JT, Sugarbaker EV, Temple WJ: Preparation of tissues for DNA flow cytometric analysis. Cytometry 1:229-237, 1980.
50. Vindeløv LL, Christensen IJ, Nissen NI: A detergent-trypsin method for the preparation of nuclei for flowcytometric DNA analysis. Cytometry 3:323-327, 1983.
51. Vindeløv LL, Christensen IJ: A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry 11:753-770, 1990.
52. Weaver DL, Bagwell CB, Hitchcox SA, Whetstone SD, Baker DR, Herbert DJ, Jones MA: Improved flow cytometric determination of proliferative activity (S-phase fraction) from paraffin-embedded tissue. Am J Clin Pathol 94:576-584, 1990.
53. Wenger CR, Beardslee S, Owens MA, Pounds G, Oldaker T, Vendely P, Pandian MR, Harrington D, Clark GM, McGuire WL: DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treat 28:9-20, 1993.
54. Wersto RP, Stetler-Stevenson M: Debris compensation of DNA histograms and its effects on S-phase analysis. Cytometry 20:43-52, 1995.
55. Witzig TE, Ingle JN, Schaid DJ, Wold LE, Barlow JF, Gonchoroff NJ, Gerstner JB, Krook JE, Grant CS, Katzmann JA: DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: Results from patients enrolled in two prospective randomized trials. J Clin Oncol 11:351-359, 1993.
56. Witzig TE, Ingle JN, Cha SS, Schaid DJ, Tabery RL, Wold LE, Grant C, Gonchoroff NJ, Katzmann JA: DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer. Cancer 74:1752-1761, 1994.
57. Wrange Ö, Nordenskjöld B, Gustafsson J-Å: Cytosol estradiol receptor in human mammary carcinoma: An assay based on isoelectric focusing in polyacrylamide gel. Anal Biochem 85:461-475, 1978.